Internal Medicine, Hematology & Oncology · Baltimore, MD
NPI
1316172240
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
22 S Greene St, Medicine, N3e09
Baltimore, MD, 21201
Phone (410) 328-6110
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$11.4M
1,771 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Michael M Green prescribed most often to Medicare patients was Lenalidomide, with 359 prescriptions and refills. In total Michael M Green wrote 1,771 Medicare prescriptions that cost $11.4M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Lenalidomide Generic | 359 | 359 | 46 | $4.3M |
| Dexamethasone Generic | 240 | 276 | 48 | $3,699 |
| Acyclovir Generic | 166 | 412 | 53 | $4,581 |
| Pomalyst Pomalidomide | 132 | 132 | 15 | $3.2M |
| Hydroxyurea Generic | 118 | 342 | 39 | $5,100 |
| Brukinsa Zanubrutinib | 74 | 74 | Under 11 | $1.0M |
| Ondansetron Hcl Generic | 56 | 56 | 25 | $431 |
| Imbruvica Ibrutinib | 36 | 36 | Under 11 | $463K |
| Nivestym Filgrastim-Aafi | 34 | 34 | 11 | $39K |
| Calquence Acalabrutinib Maleate | 33 | 33 | Under 11 | $475K |
| Venclexta Venetoclax | 32 | 32 | Under 11 | $286K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 31 | 31 | 11 | $1,129 |
| Cholestyramine Cholestyramine (With Sugar) | 28 | 29 | Under 11 | $1,339 |
| Prednisone Generic | 24 | 24 | Under 11 | $245 |
| Prochlorperazine Maleate Generic | 24 | 24 | 11 | $329 |
Brand drugs: - claims; generic drugs: 1,273 claims; opioid claims: 76.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Michael M Green were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.